eracal

Kailera

This biopharmaceutical company develops injectable and oral therapies for the treatment of obesity and related metabolic conditions.

Metsera

The company develops injectable and oral medicines for patients with obesity and metabolic diseases.

Ousia Pharma

This biotechnology company develops peptide-drug conjugates to treat obesity and cardiometabolic diseases for patients requiring improved metabolic health and weight regulation.

Carmot Therapeutics

This biotechnology company develops drug therapies to treat metabolic diseases, such as obesity and diabetes, for patients with these conditions.

OrsoBio

The company develops medicinal therapies targeting energy metabolism pathways for patients with obesity, diabetes, and other severe metabolic disorders.

Tanai Therapeutics

This company develops oral small molecule therapeutics targeting energy expenditure pathways to treat obesity and cardiometabolic diseases for patients.

Aardvark Therapeutics

This biopharmaceutical company develops small-molecule therapies for patients with metabolic diseases, obesity, and rare conditions like Prader-Willi Syndrome to suppress hunger.

Resalis Therapeutics

This company develops non-coding RNA therapies to treat metabolic disorders, including obesity and fatty liver disease, for patients with unmet medical needs.